The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells

Journal of Immunology

Volumn 161, Issue 12, 1998, Pages 6924-6930

  Van Den Berg, Rocco H ^a   Faber Krol, Maria C ^a   Sim, Robert B ^b   Dana, Mohamed R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; CYCLOHEXIMIDE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

AEROBIC METABOLISM; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD VESSEL PERMEABILITY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CROSS LINKING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RECEPTOR UPREGULATION; UMBILICAL VEIN;

ANIMALS; ANTIBODIES, MONOCLONAL; CALCIUM-BINDING PROTEINS; CALRETICULIN; CELLS, CULTURED; CHEMOKINE CCL2; COMPLEMENT C1Q; COMPLEMENT FACTOR H; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN M; INTERLEUKIN-6; INTERLEUKIN-8; PEPTIDE FRAGMENTS; PROTEIN SYNTHESIS INHIBITORS; RABBITS; RIBONUCLEOPROTEINS; RNA, MESSENGER; STIMULATION, CHEMICAL; UMBILICAL VEINS;

EID: 0032534734     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. Andrews, B. S., M. Shadforth, P. Cunningham, and J. S. Davis IV. 1981. Demonstration of a C1q receptor on the surface of human endothelial cells. J. Immunol. 127:1075.
2. Linder, E. 1981. Binding of C1q and complement activation by vascular endothelium. J. Immunol. 126:648.
3. Peerschke, E. I. B., R. Malhotra, B. Ghebrehiwet, K. B. M. Reid, A. C. Willis, and R. B. Sim. 1993. Isolation of a human endothelial cell C1q receptor (C1qR). J. Leukocyte Biol. 53:179.
4. Bordin, S., W. P. Kolb, and R. C. Page. 1983. C1q receptors on cultured human gingival fibroblasts: analysis of binding properties. J. Immunol. 130:1871.
5. Bordin, S., M. Smith, B. Ghebrehiwet, D. Oda, and R. C. Page. 1992. Smooth muscle and epithelial cells express specific binding sites for the C1q component of complement. Clin. Immunol. Immunopathol. 63:51.
6. Peerschke, E. I. B., and B. Ghebrehiwet. 1987. Human blood platelets possess specific binding sites for C1q. J. Immunol. 138:1537.
7. Young, K. R., J. L. Ambrus, A. Malbran, A. S. Fauci, and A. J. Tenner. 1991. Complement subcomponent C1q stimulates immunoglobulin production by human B lymphocytes. J. Immunol. 146:3356.
8. Hamada, A., and B. M. Greene. 1987. C1q enhancement of IgG-dependent eosinophil-mediated killing of Schistosomula in vitro. J. Immunol. 138:1240.
9. Bobak, D. A., M. M. Frank, and A. J. Tenner. 1986. Characterization of C1q receptor expression on human phagocytic cells: effects on PDBu and fMLP. J. Immunol. 136:4604.
10. Bobak, D. A., T. G. Gaither, M. M. Frank, and A. J. Tenner. 1988. Modulation of FcR function by complement subcomponent C1q enhances the phagocytosis of IgG-opsonized targets by human monocytes and culture-derived macrophages. J. Immunol. 138:1150.
11. Bobak, D. A., M. M. Frank, and A. J. Tenner. 1988. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes. Eur. J. Immunol. 18:2001.
12. Sorvillo, J. M., I. Gigli, and E. Pearlstein. 1986. The effect of fibronectin on the processing of C1q-and C3b/bi-coated immune complexes by peripheral blood monocytes. J. Immunol. 136:1023.
13. Tenner, A. J., R. Young, A. Malbran, A. S. Fauci, and J. L. Ambrus, Jr. 1987. In vitro modulation of B cell immunoglobulin (Ig) synthesis by the C1q subcomponent of complement. Fed. Proc. 46:1195.
14. Tenner, A. J., and N. R. Cooper. 1982. Stimulation of a human polymorphonuclear leukocyte oxidative response by the C1q subunit of the first complement component. J. Immunol. 128:2547.
15. Ryan, U. S., J. D. Goodwin, J. M. Vann, and D. R. Schultz. 1981. Effect of C1q on phagocytosis of Salmonella minnesota by endothelium. Complement 4:220.
16. Lozada, C., R. I. Levin, M. Huie, R. Hirschhorn, D. Naime, M. Whitlow, P. A. Recht, B. Golden, and B. N. Cronstein. 1995. Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1. Proc. Natl. Acad. Sci. USA 92:8378.
17. Ghebrehiwet, B., B.-L. Lim, E. I. B. Peerschke, A. C. Willis, and K. B. M. Reid. 1994. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q. J. Exp. Med. 179:1809.
18. Eggleton, P., B. Ghebrehiwet, K. N. Sastry, J. Coburn, K. S. Zaner, K. B. M. Reid, and A. I. Tauber. 1995. Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. J. Clin. Invest. 95:1569.
19. Malhotra, R., A. C. Willis, J. C. Jensenius, J. Jackson, and R. B. Sim. 1993. Structure and homology of human C1q receptor (collectin receptor). Immunology 78:341.
20. Eggleton, P., T. S. Lieu, E. G. Zappi, K. Sastry, J. Coburn, K. S. Zaner, R. D. Sontheimer, J. D. Capra, B. Ghebrehiwet, and A. I. Tauber. 1994. Calreticulin is released from activated neutrophils and binds to C1q and mannan-binding protein. Clin. Immunol. Immunopathol. 72:405.
21. Jonsson, H., and G. Sturfelt. 1990. A novel assay for neutrophil clustering activity of human sera: relation to disease activity and neutropenia in systemic lupus erythematosus. Ann. Rheum. Dis. 49:46.
22. Daha, M. R., L. Dunn, R. H. van den Berg, Y. Muizert-de Lange, A. F. Gerritsen, and L. A. van Es. 1993. Isolation of a human endothelial cell C1q receptor. Mediat. Inflamm. 2:447.
23. Guan, E., S. L. Robinson, E. B. Goodman, and A. J. Tenner. 1994. Cell-surface protein identified on phagocytic cells modulates the C1q-mediated enhancement of phagocytosis. J. Immunol. 152:4005.
24. Ghebrehiwet, B., R. R. Kew, B. L. Gruber, M. J. Marchese, E. I. B. Peerschke, and K. B. M. Reid. 1995. Murine mast cells express two types of C1q receptor that are involved in the induction of chemotaxis and chemokinesis. J. Immunol. 155:2614.
25. Nepomuceno, R. R., A. H. Henschen-Edman, W. H. Burgess, and A. J. Tenner. 1997. cDNA cloning and primary structure analysis of C1qR(P). the human C1q/ MBL/SPA receptor that mediates enhanced phagocytosis in vitro. Immunity 6:119.
26. Herwald, H., J. Dedio, R. Kellner, M. Loos, and W. Muller-Esterl. 1996. Isolation and characterization of the kininogen-binding protein P33 from endothelial cells: identity with the gC1qR receptor. J. Biol Chem. 271:13040.
27. van den Berg, R. H., F. Prins, M. C. Faber-Krol, N. J. Lynch, W. Schwaeble, L. A. van Es, and M. R. Daha. 1997. Intracellular localization of the human receptor for the globular domains of C1q. J. Imnmnol. 158:3909.
28. Dedio, J., W. Jahnen-Dechent, M. Bachmann, and W. Muller-Esterl. 1998. The multiligand-binding protein gC1qR. putative C1q receptor, is a mitochondrial protein. J. Immunol. 160:3534.
29. Wing, M. G., D. J. Seilly, D. J. Bridgman, and R. A. Harrison. 1993. Rapid isolation and biochemical characterization of rat C1 and C1q. Mol. Immunol. 30:433.
30. Kolb, W. P., L. M. Kolh, and E. R. Podack. 1979. C1q: isolation from human serum in high yield by affinity chromatography and development of a highly sensitive hemolytic assay. J. Immunol. 122:2103.
31. Daha, M. R., N. Klar, R. Hoekzema, and L. A. van Es. 1990. Enhanced IgG production by human peripheral lymphocytes induced by aggregated C1q. J. Immunol. 144:12.
32. 2 tetrameres. Mol. Immunol. 20: 53.
33. Hoekzema, R., M. Martens, M. C. Brouwer, and L. E. Hack. 1988. The distortive mechanism for the activation of complement component C1, supported by studies with a monoclonal antibody against the "arms" of C1q. Mol. Immunol. 25:485.
34. Jaffe, E. A., R. L. Nachman, C. G. Becker, and C. R. Minick. 1981. Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52:2745.
35. Maciag, T., J. Cerundolo, J. Isley, P. R. Kelley, and F. Forand. 1979. An endothelial growth factor from bovine hypothalamus: identification and partial characterization. Proc. Acad. Natl. Sci. USA 76:5674.
36. Berger, S. P., M. A. Seelen, P. S. Hiemstra, J. S. Gerritsma, E. Heemskerk, F. J. van der Woude, and M. R. Daha. 1996. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro. J. Am. Soc. Nephrol. 7:694.
37. Kijlstra, A., A. van der Lelij, W. Knutson, G. J. Fleuren, and L. A. van Es. 1978. The influence of phagocyte function on glomerular localization of aggregated IgM in rats. Clin. Exp. Immunol. 32:207.
38. Malhotra, R., A. C. Willis, A. Lopez Bernal, S. Thiel, and R. B. Sim. 1994. Mannan-binding protein levels in human amniotic fluid during gestation and its interaction with collcctin receptor from amnion cells. Immunology 82:439.
39. Crockard, A. D., J. M. Thompson, R. Malhotra, and T. A. McNeill. 1993. Increased expression of C1q receptors on neutrophils from inflammatory joint fluids. Immunol. Lett. 36:195.
40. Kijlstra, A., L. A. van Es, and M. R. Daha. 1979. Enhanced degradation of soluble immunoglobulin aggregates by macrophages in the presence of complement. Immunology 37:673.
41. Chomczynski, P., and N. Sacchi. 1987. Single step method of isolation by acid quanidinium thioglycanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
42. van den Dobbelsteen, M. E. A., V. Verhasselt, and J. G. J. Kaashoek. 1994. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by interleukin 1 and interferon-γ. Clin. Exp. Immunol. 95:173.
43. Wong, G. G., G. Witek-Giannotti, R. M. Hewick, S. C. Clark, and M. Ogawa. 1988. Interleukin 6: identification as a hematopoietic colony stimulating factor. Behring Inst. Mitt. 83:40.
44. Hotta, K., K. Havashi, J. Ishikawa, M. Tagawa, K. Hashimoto, S. Hizumo, and K. Suzuki. 1990. Coding region structure of interleukin-8 gene of human lung giant cell carcinoma LU65C cells that produce LUCT/interleukin-8: homogeneity in interleukin-8 genes. Immunol. Lett. 24:165.
45. Rollins, B. J., P. Stier, and T. Ernst. 1989. The human homolog of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9:4687.
46. Ponte, P., N. Engel, and P. Gunning. 1984. Evolutionary conservation in the untranslated regions of actin mRN As: DNA sequence of a human β-actin cDNA. Nucleic Acids Res. 12:1687.
47. Prodjosudjadi, W., J. S. J. Gerritsma, L. A. van Es, M. R. Daha, and J. A. Bruijn. 1995. Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis. Clin. Nephrol. 44:148.
48. Dauchel, H., N. Julen, C. Lemercier, M. Daveau, D. Ozanne, M. Fontaine, and J. Ripoche. 1990. Expression of complement alternative pathway proteins by endothelial cells: differential regulation by interleukin 1 and glucocorticoids. Eur. J. Immunol. 20:1669.
49. Brooimans, R. A., P. S. Hiemstra, A. A. van der Ark, R. B. Sim, L. A. van Es, and M. R. Daha. 1989. Biosynthesis of complement factor H by human umbilical vein endothelial cells: regulation by T cell growth factor and IFN-gamma. J. Immunol. 142:2024.
50. Coremans, I. E. M., W. M. J. M. Bogers, R. K. Stad, E. A. M. van der Voort, F. A. Prins, N. van Rooijen, F. C. Breedveld, and M. R. Daha. 1993. Role of liver endothelial and Kupffer cells in clearance of human C1q in rats. Eur. J. Immunol. 23:1942.
51. Daha, M. R., A. M. M. Miltenburg, P. S. Hiemstra, N. Klar-Mohamad, L. A. van Es, and V. W. M. van Hinsbergh. 1988. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro. Eur J. Immunol. 18:783.
52. Ghebrehiwet, B., P. D. Lu, W. Zhang, S. A. Keilbaugh, L. E. A. Leigh, P. Eggleton, K. B. M. Reid, and E. I. B. Peerschke. 1997. Evidence that the two C1q binding membrane proteins, gC1qR and cC1qR. associate to form a complex. J. Immunol. 159:1429.
53. Leigh, L. E., B. Ghebrehiwet, T. P. Perera, I. N. Bird, P. Strong, U. Kishore, K. B. Reid, and P. Eggleton. 1998. C1q-mediated chemotaxis by human neutrophils: involvement of gC1qR and G-protein signalling mechanisms. Biochem. J. 330:247.
54. Dedio, J., and W. Muller-Esterl. 1996. Kininogen binding protein p33/gC1qR is localized in the vesicular fraction of endothelial cells. FEBS Lett. 399:255.
55. Lim, B. L., K. B. M. Reid, B. Ghebrehiwet, E. I. B. Peerschke, L. A. E. Leigh, and K. T. Preissner. 1996. The binding protein for globular heads of complement C1q, gC1qR. J. Biol. Chem. 271:26739.
56. Peerschke, E. I. B., K. B. M. Reid, and B. Ghebrehiwet. 1994. Identification of a novel 33-kDa C1q-binding site on human blood platelets. J. Immunol. 152: 5896.
57. Dedhar, S. 1994. Novel functions for calreticulin: interaction with integrins and modulation of gene expression? Trends Biochem. Sci. 19:269.
58. Wada, I., S. Imai, M. Kai, F. Sakane, and H. Kanoh. 1995. Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored forms. J. Biol. Chem. 270:20298.
59. Ghebrehiwet, B., L. Silvestri, and C. McDevitt. 1984. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. J. Exp. Med. 160:1375.
60. Ghebrehiwet, B., S. Bossone, A. Erdei, and K. B. M. Reid. 1988. Reversible biotinylation of C1q with a cleavable biotinyl derivative. J. Immunol. Methods 110:251.
61. Malhotra, R., and R. B. Sim. 1989. Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q. Biochem. J. 262:625.
62. Chen, A., S. Gaddipati, Y. Hong, D. J. Volkman, E. I. B. Peerschke, and B. Ghebrehiwet. 1994. Human T cells express specific binding sites for C1q. J. Immunol. 153:1430.
63. D'Cruz, O. J., C. A. Toth, and G. G. Haas. 1996. Recombinant soluble human complement receptor type 1 inhibits antisperm antibody-and neutrophil-mediated injury to human sperm. Biol. Reprod. 54:1217.
64. Bordin, S., B. Ghebrehiwet, and R. C. Page. 1990. Participation of C1q and its receptor in adherence of human diploid fibroblast. J. Immunol. 145:2520.
65. Peerschke, E. I. B., K. B. M. Reid, and B. Ghebrehiwet. 1993. Platelet activation by C1q results in the induction of ?IIb/?3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J. Exp. Med. 178:579.
66. van den Berg, R. H., M. C. Faber-Krol, L. A. van Es, and M. R. Dana. 1995. Regulation of the function of the first component of complement by human C1q receptor. Eur. J. Immunol. 25:2206.
67. Ryan, U. S., D. R. Schultz, J. D. Goodwin, J. M. Vann, M. P. Selvaraj, and M. A. Hart. 1989. Role of C1q in phagocytosis of Salmonella minnesota by pulmonary endothelial cells. Infect. Immun. 57:1356.
68. Helle, M., L. Boeije, and L. A. Aarden. 1989. Interleukin-6 is an intermediate in interleukin-1 induced thymocyte proliferation. J. Immunol. 142:4335.
69. Helle, M., J. P. J. Brakenhoff, E. R. de Groot, and L. A. Aarden. 1988. Interleukin-6 is involved in interleukin-1-induced activities. Eur. J. Immunol. 18:957.
70. Gauldie, J., C. Richards, D. Harnish, P. M. Lansdorp, and H. Baumann. 1987. Interferon γ2/B-cell stimulatory factor type-2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute-phase protein response in liver cells. Proc. Natl. Acad. Sci. USA 84:7251.
71. Fey, G. H., and J. Gauldie, 1990. The acute-phase response of the liver in inflammation. In Progress in Liver Disease. H. Popper and F. Schaffner, eds. Saunders, Philadelphia, p. 89.
72. Watson, C., S. Whittaker, N. Smith, A. J. Vora, D. C. Dumonde, and K. A. Brown. 1996. IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin. Exp. Immunol. 105:112.
73. Aderka, D., J. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:3517.
74. Schindler, R., J. Mancilla, S. Endres, R. Ghorbani, S. C. Clark, and C. A. Dinarello. 1990. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40.
75. Tilg, H., E. Trehu, M. B. Atkins, C. A. Dinarello, and J. W. Mier. 1994. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83:113.
76. Tilg, H., E. Vannier, G. Vachino, C. A. Dinarello, and J. W. Mier. 1993. Anti-inflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1-β synthesis by human peripheral blood mononuclear cells. J. Exp. Med. 178:1629.
77. Furie, M. B., and G. J. Randolph. 1995. Chemokines and tissue injury. Am. J. Pathol. 147:1287.
78. Kennedy, J., G. S. Keiner, and S. Kleyensteuber. 1995. Molecular cloning and functional characterization of human lymphotactin. J. Immunol. 155:203.
79. Taub, D. D., A. R. Lloyd, and K. Conlon. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
80. Miller, M. D., and M. S. Krangel. 1992. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit. Rev. Immunol. 12:17.
81. Gimbrone, M. A. J., M. S. Obin, A. F. Brock, E. A. Luis, P. E. Hass, C. A. H'bert, Y. K. Yip, D. W. Leung, D. G. Lowe, W. J. Kohr, et al. 1989. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 246:1601.
82. Koga, S., S. Morris, S. Ogawa, H. Liao, J. P. Bilezikian, G. Chen, W. J. Thompson, T. Ashikaga, J. Brett, and D. M. Stern. 1995. TNF modulates endothelial properties by decreasing cAMP. Am. J. Physiol. 268:1104.
83. Gamble, J. R., J. M. Harlan, and S. J. Klebanoff. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:8667.
84. Le, J., and J. Vilcek. 1987. Biology of disease: tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 56:234.
85. Marfaing-Koka, A., O. Devergne, G. Gorgone,. A. Portier, T. J. Schall, P. Galanaud, and D. Emilie. 1995. Regulation of the production of the RANTES chemokine by endothelial cells. J. Immunol. 154:1870.
86. Strieter, R. M., S. L. Kunkel, H. J. Showell, D. G. Remick, S. H. Phan, P. A. Ward, and R. M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243:1467.
87. Sica, A., K. Matsushima, J. van Damme, J. M. Wang, N. Polentarutti, E. Dejana, F. Colotta, and A. Mantovani. 1990. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 69:548.